AAM
KITE

Alpine Associates Management’s Kite Pharma, Inc. KITE Stock Holding History

Alpine Associates Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-252,600
Closed -$45.4M – 66
2017
Q3 		$45.4M Buy
+252,600
New +$35.2M 1.53% 20

Alpine Associates Management's KITE Position: Q4 2017 in Review

Alpine Associates Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 397,105 shares — an estimated $71.4M sold.

Alpine Associates Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $71.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Alpine Associates Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Alpine Associates Management sold 397,105 Kite Pharma, Inc. shares in Q4 2017, an estimated $71.4M.
  • Alpine Associates Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Alpine Associates Management's Kite Pharma, Inc. position peaked at $71.4M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Alpine Associates Management's 13F filing for Q4 2017, filed 8 Feb 2018.